drugset / Trial / NCT02624102

Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression

NCT02624102

RandomizedParallel-groupTriple-blindTreatment

Summary

Major Depressive Disorder (MDD) is a mood disorder, highly prevalent in Brazil and in world. The treatments of choice are the psychotropic drugs of the class of antidepressants and Behavioral or Cognitive Behavior Therapy (CBT). The aim of this study is to compare the efficacy of Trial Based Cognitive Therapy with the Behavioral Activation and pharmacotherapy in the treatment of MDD in a randomized clinical trial witch 96 patients with MDD,

Timeline

Start
2015-09
Primary completion
2017-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Background Bupropion Small molecule
Background Citalopram Small molecule
Background Escitalopram Small molecule
Background Fluoxetine Small molecule